Pharmacogenetics.
D000123:Acetyltransferases / Q000096:biosynthesis; D000287:Administration, Topical; D000483:Alleles; D000700:Analgesics / Q000009:adverse effects; D000743:Anemia, Hemolytic / Q000139:chemically induced; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D001049:Apnea / Q000139:chemically induced; D001483:Base Sequence; D004247:DNA; D005796:Genes; D005938:Glucocorticoids; D005955:Glucosephosphate Dehydrogenase Deficiency; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D008305:Malignant Hyperthermia / Q000235:genetics; D008661:Metabolism, Inborn Errors / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000096:biosynthesis; D008967:Molecular Biology; D009443:Neuritis / Q000139:chemically induced; D010597:Pharmacogenetics; D010672:Phenytoin / Q000009:adverse effects; D013390:Succinylcholine / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D013450:Sulfones / Q000009:adverse effects
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D005938:Glucocorticoids; D013449:Sulfonamides; D013450:Sulfones; D010672:Phenytoin; D004247:DNA; D006899:Mixed Function Oxygenases; D000123:Acetyltransferases; D013390:Succinylcholine; D007538:Isoniazid